Inventor
LIVINGSTON DOUGLAS ALAN
US15 patents
⚠️ This page may combine multiple inventors who share the name “LIVINGSTON DOUGLAS ALAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JOLLA PHARMA
5 patentsUS5726329AMar 10, 1998
Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
JOLLA PHARMA53 citations95
US7351855B2Apr 1, 2008
Chemically defined non-polymeric valency platform molecules and conjugates thereof
JOLLA PHARMA24 citations92
US5874552AFeb 23, 1999
Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
JOLLA PHARMA29 citations92
US6166198ADec 26, 2000
Methods for oligonucleotide synthesis
JOLLA PHARMA12 citations73
US7115581B2Oct 3, 2006
Chemically-defined non-polymeric valency platform molecules and conjugates thereof
JOLLA PHARMA1 citations52
GLAXO WELLCOME INC
5 patentsUS5840990ANov 24, 1998
Intermediates to carbocyclic nucleosides
GLAXO WELLCOME INC18 citations92
US5808147ASep 15, 1998
Therapeutic nucleosides
GLAXO WELLCOME INC13 citations82
US5641889AJun 24, 1997
Therapeutic nucleosides
GLAXO WELLCOME INC14 citations82
US6355646B1Mar 12, 2002
Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl)phenyl derivatives, their preparation and their use in treatment of inflammatory conditions and immune disorders
GLAXO WELLCOME INC7 citations73
US5919941AJul 6, 1999
Intermediates for the preparation of sulphonic acid salts of 4-amino-2-cyclopentene-1-carboxylic acid
GLAXO WELLCOME INC7 citations73
SMITHKLINE BEECHAM CORP
3 patentsUS6437124B1Aug 20, 2002
Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl) phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
SMITHKLINE BEECHAM CORP11 citations73
US6392085B2May 21, 2002
Therapeutic nucleosides
SMITHKLINE BEECHAM CORP7 citations73
US7002012B2Feb 21, 2006
Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-YI)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
SMITHKLINE BEECHAM CORP0 citations51